Access the full text.
Sign up today, get DeepDyve free for 14 days.
T. Dudding, C. Vaizey, A. Gibbs, M. Kamm (2009)
Improving the efficacy of sacral nerve stimulation for faecal incontinence by alteration of stimulation parametersBritish Journal of Surgery, 96
T. Dudding, David Parés, C. Vaizey, M. Kamm (2008)
Predictive factors for successful sacral nerve stimulation in the treatment of faecal incontinence: a 10‐year cohort analysisColorectal Disease, 10
J. Melenhorst, S. Koch, Ö. Uludağ, W. Gemert, C. Baeten (2007)
Sacral neuromodulation in patients with faecal incontinence: results of the first 100 permanent implantationsColorectal Disease, 9
F. Penninckx (2004)
Belgian experience with dynamic graciloplasty for faecal incontinenceBritish Journal of Surgery, 91
D. Deng, M. Gulati, Matthew Rutman, S. Raz, L. Rodríguez (2006)
Failure of sacral nerve stimulation due to migration of tined lead.The Journal of urology, 175 6
K. Matzel, P. Lux, S. Heuer, M. Besendörfer, W. Zhang (2009)
Sacral nerve stimulation for faecal incontinence: long‐term outcomeColorectal Disease, 11
P. Lunniss, M. Gladman, F. Hetzer, N. Williams, S. Scott (2004)
Risk factors in acquired faecal incontinence.Journal of the Royal Society of Medicine, 97 3
C. Vaizey, E. Carapeti, J. Cahill, M. Kamm (1999)
Prospective comparison of faecal incontinence grading systemsGut, 44
C. Vaizey, M. Kamm, I. Turner, R. Nicholls, J. Woloszko (1999)
Effects of short term sacral nerve stimulation on anal and rectal function in patients with anal incontinenceGut, 44
N. Kenefick, C. Vaizey, Richard Cohen, R. Nicholls, M. Kamm (2002)
Medium‐term results of permanent sacral nerve stimulation for faecal incontinenceBritish Journal of Surgery, 89
D. Altomare, C. Ratto, E. Ganio, P. Lolli, A. Masin, R. Villani (2009)
Long-Term Outcome of Sacral Nerve Stimulation for Fecal IncontinenceDiseases of the Colon & Rectum, 52
T. Dudding, C. Vaizey, M. Kamm (2008)
Obstetric Anal Sphincter Injury: Incidence, Risk Factors, and ManagementAnnals of Surgery, 247
M. McLennan (2003)
The role of electrodiagnostic techniques in the reprogramming of patients with a delayed suboptimal response to sacral nerve stimulationInternational Urogynecology Journal, 14
Sacral nerve stimulation for faecal incontinence Ó 2011 The Authors Colorectal Disease Ó 2011 The Association of Coloproctology of Great Britain and Ireland
K. Matzel, U. Stadelmaie, F. Gall, M. Hohenfellner (1995)
Electrical stimulation of sacral spinal nerves for treatment of faecal incontinenceThe Lancet, 346
L. Smith, J. Jorge, S. Wexner (1993)
Etiology and management of fecal incontinenceDiseases of the Colon & Rectum, 36
J. Melenhorst, S. Koch, Ö. Uludağ, W. Gemert, C. Baeten (2008)
Is a morphologically intact anal sphincter necessary for success with sacral nerve modulation in patients with faecal incontinence?Colorectal Disease, 10
C. Vaizey, M. Kamm (2005)
Injectable bulking agents for treating faecal incontinenceBritish Journal of Surgery, 92
Linda Mundy, T. Merlin, G. Maddern, J. Hiller (2004)
Systematic review of safety and effectiveness of an artificial bowel sphincter for faecal incontinenceBritish Journal of Surgery, 91
Aim Sacral nerve stimulation (SNS) is considered a first‐line surgical treatment option for faecal incontinence. There is little information on long‐term results. The results of SNS for faecal incontinence performed at a single centre over a 10‐year period are reported. Method A cohort analysis of consecutive patients treated with SNS for faecal incontinence over a 10‐year period was carried out. Data were collected prospectively using bowel habit diaries and St Mark’s and Cleveland Clinic incontinence scores. Treatment success was defined as a > 50% reduction in episodes of faecal incontinence compared with baseline. Results Temporary SNS was performed in 118 patients, and 91 (77%) were considered suitable for chronic stimulation. The median period of follow up was 22 (1–138) months. Seventy patients were followed for 1 year with success in 63 (90%). Of 18 patients followed for 5 years, 15 (83%) reported continued success, 11 (61%) maintained full efficacy, 4 (22%) reported some loss, and 3 (17%) reported complete loss. Three patients with a 10‐year follow up had no loss in efficacy. Overall, complete loss of efficacy was observed in 14 (16%) patients at a median of 11.5 months following implantation. A further 5 (6%) patients showed deterioration with time. In 9 (47%), no reason for the deterioration in symptoms could be identified. Conclusions SNS can be effective for up to 10 years. Some patients experience deterioration in symptoms over time. The reasons for this are often not evident.
Colorectal Disease – Wiley
Published: Sep 1, 2011
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.